Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

The diagnosis of hereditary hemorrhagic telangiectasia (HHT) is based on the Curaçao criteria: epistaxis, telangiectases, arteriovenous malformations in internal organs, and family history. Genetically speaking, more than 90% of HHT patients show mutations in <i>ENG</i> or <i>ACVRL...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Virginia Albiñana, Angel M Cuesta, Isabel de Rojas-P, Eunate Gallardo-Vara, Lucía Recio-Poveda, Carmelo Bernabéu, Luisa María Botella
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2020-06-01
Serie:Journal of Clinical Medicine
Soggetti:
HHT
ALK1
endoglin
raloxifene
bazedoxifene
tranexamic acid
Accesso online:https://www.mdpi.com/2077-0383/9/6/1766
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi